IP Library Granted Patent US 8,016,740
Granted Patent B2
US 8,016,740 · App. 12/475,918 · Granted Sep 13, 2011

Pressure attenuation device

Assignee: Attenuex Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,016,740
App. No.
12/475,918
Granted
Sep 13, 2011
Kind
B2
Abstract

A therapeutic device is provided. The therapeutic device can include a flexible housing and can be configured to be positioned within an anatomical structure. The therapeutic device can also include at least one high vapor pressure media having a vapor pressure greater than the pressure within the anatomical structure and a permeability of less than 1 ml/day at body temperature through said outer wall.

Claims (26)

1. A therapeutic device, comprising:

a flexible housing comprising an outer wall defining a chamber therein, said housing configured to be positioned within an anatomical structure while in a first, introduction configuration and then at least partially expanded into a second, implanted configuration; and

at least one high vapor pressure media having a vapor pressure greater than the pressure within the anatomical structure and a permeability of less than 1 ml/day at body temperature through said outer wall.

2. The device in claim 1 , wherein said second configuration is operable to attenuate pressure spikes within said anatomical structure by reversibly reducing in volume in response to said pressure spikes.

3. The device in claim 1 , wherein said housing forms a toroid.

4. The device in claim 1 , wherein said housing forms a toroid with a central region further comprising a membrane.

5. The device in claim 1 , wherein said device carries a therapeutic substance and wherein said device is operable to release said substance.

6. The device in claim 1 , wherein said device carries a diagnostic substance and wherein said device is operable to release said substance.

7. The device in claim 1 , wherein said device carries a signaling device.

8. The device in claim 1 , wherein said device carries a therapeutic agent; wherein said device is programmed to deliver said therapeutic agent in a continuous or bolus presentation.

9. The device in claim 1 , wherein said device further comprises a valve and is programmed to be responsive to physiological stimuli.

10. The device in claim 1 , further comprising a valve programmed to be responsive to a remote signal.

11. The device in claim 1 , wherein said device is coated to inhibit the deposition of materials present in the anatomical structure.

12. The device in claim 1 , further comprising a pressure monitor.

13. The device in claim 1 , wherein said device is configured to record or transmit information.

14. The device in claim 1 , wherein said device is comprised of more than one housing.

15. The device in claim 1 , further comprising a fuse.

16. The device in claim 1 , wherein said high vapor pressure media comprises one or more of sulfur hexafluoride, hexafluoroethane, perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane, perfluorohepane, perfluorooctane, perfluorodecalin, octafluoropropane, decafluoro-n-butane, perfluorooctylbromide, heptafluoropropane, perfluoroperhydrophenanthrene and tetrafluoroethane.

17. The device in claim 1 , wherein said housing defines a volume between 1 and 100 cc.

18. The device in claim 1 , wherein said device is operable to reduce the rate in a rise of pressure within said anatomical structure.

19. A method of treating a patient, comprising the steps of:

providing a compressible attenuation device which is moveable from a first, introduction configuration to a second, implanted configuration;

introducing the attenuation device into the anatomical structure while in the first configuration;

transforming the attenuation device within the anatomical structure to the second configuration; and

attenuating a pressure change within the anatomical structure by reversibly changing the volume of the attenuation device in response to the pressure change;

introducing within the attenuation device at least one high vapor pressure media having a vapor pressure greater than said anatomical structure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: ATTENUEX TECHNOLOGIES, INC.
To: SOLACE THERAPEUTICS, INC.
Reel/Frame 049282/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2017
From: CONNORS, KEVIN G.; LIDDICOAT, JOHN R.
To: ATTENUEX TECHNOLOGIES, INC.
Reel/Frame 041207/0568 →
Continuity (9)
Continuation 11527333 · Sep 26, 2006
Continuation In Part 11314601 · Dec 20, 2005
Continuation 10618571 · Jul 11, 2003
Continuation 10391446 · Mar 17, 2003
Continuation In Part 09723309 · Nov 27, 2000
Provisional Application 60721834 · Sep 26, 2005
Provisional Application 60415949 · Oct 3, 2002
Provisional Application 60197095 · Apr 14, 2000
Related Publication 20090240277A1 · Sep 24, 2009